Skip to main content

Table 5 Multivariate Cox proportional hazard analysis for OS in ADC

From: Role of Synaptophysin, Chromogranin and CD56 in adenocarcinoma and squamous cell carcinoma of the lung lacking morphological features of neuroendocrine differentiation: a retrospective large-scale study on 1170 tissue samples

Variable

HR (CI95)

p value

Stage II

2.76 (1.576–3.581)

< 0.001a

Stage III

4.649 (3.276–6.597)

< 0.001a

Stage IV

6.729 (3.726–12.155)

< 0.001a

Age (> 59 versus < 59 years)

1.036 (0.776–1.384)

0.809

Gender (female versus male)

0.564 (0.420–0.757)

< 0.001

Neuroendocrine marker (positivity versus negativity)

0.876 (0.616–1.247)

0.463

  1. n = 617
  2. aas compared to Stage I
  3. OS overall survival